Show simple item record

dc.contributor.authorKing, L.A.
dc.contributor.authorCorkery, John
dc.date.accessioned2018-11-17T02:12:20Z
dc.date.available2018-11-17T02:12:20Z
dc.date.issued2018-07-01
dc.identifier.citationKing , L A & Corkery , J 2018 , ' An index of fatal toxicity for new psychoactive substances ' , Journal of Psychopharmacology , vol. 32 , no. 7 , pp. 793-801 . https://doi.org/10.1177/0269881118754709
dc.identifier.issn0269-8811
dc.identifier.otherORCID: /0000-0002-3849-817X/work/62749078
dc.identifier.urihttp://hdl.handle.net/2299/20794
dc.descriptionThe final, definitive version of this paper has been published in Journal of Psychopharmacology, February 2018, published by SAGE Publishing, All rights reserved.
dc.description.abstractAn index of fatal toxicity for new psychoactive substances has been developed based solely on information provided on death certificates. An updated index of fatal toxicity (T f), as first described in 2010, was calculated based on the ratio of deaths to prevalence and seizures for the original five substances (amphetamine, cannabis, cocaine/crack, heroin and 3,4-methylenedioxymethylamphetamine) *. These correlated well with the 2010 index. Deaths were then examined for cases both where the substance was and was not found in association with other substances. This ratio (sole to all mentions; S/A) was then calculated for deaths in the period 1993 to 2016. This new measure of fatal toxicity, expressed by S/A, was well-correlated with the index L n (T f) of the original reference compounds. The calculation of S/A was then extended to a group of new psychoactive substances where insufficient prevalence or seizure data were available to directly determine a value of T f by interpolation of a graph of T f versus S/A. Benzodiazepine analogues had particularly low values of S/A and hence T f. By contrast, γ-hydroxybutyrate/γ-butyrolactone, α-methyltryptamine, synthetic cannabinoid receptor agonists and benzofurans had a higher fatal toxicity.en
dc.format.extent9
dc.format.extent752163
dc.language.isoeng
dc.relation.ispartofJournal of Psychopharmacology
dc.subjectavailability
dc.subjectdrug users
dc.subjectlegal highs
dc.subjectMortality statistics
dc.subjectnew psychoactive substances
dc.subjectprevalence
dc.subjectPharmacology
dc.subjectPsychiatry and Mental health
dc.subjectPharmacology (medical)
dc.titleAn index of fatal toxicity for new psychoactive substancesen
dc.contributor.institutionCentre for Clinical Practice, Safe Medicines and Drug Misuse Research
dc.contributor.institutionDepartment of Pharmacy, Pharmacology and Postgraduate Medicine
dc.contributor.institutionPsychopharmacology, Drug Misuse and Novel Psychoactive Substances Unit
dc.contributor.institutionCentre for Health Services and Clinical Research
dc.contributor.institutionSchool of Life and Medical Sciences
dc.contributor.institutionDepartment of Clinical and Pharmaceutical Sciences
dc.description.statusPeer reviewed
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85049989821&partnerID=8YFLogxK
rioxxterms.versionofrecord10.1177/0269881118754709
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record